| Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy S Dahbour, F Jamali, D Alhattab, A Al‐Radaideh, O Ababneh, N Al‐Ryalat, ... CNS neuroscience & therapeutics 23 (11), 866-874, 2017 | 139 | 2017 |
| An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells D Alhattab, F Jamali, D Ali, H Hammad, S Adwan, R Rahmeh, O Samarah, ... Regenerative medicine 14 (9), 841-865, 2019 | 22 | 2019 |
| The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study AA Alghwiri, F Jamali, M Aldughmi, H Khalil, A Al-Sharman, D Alhattab, ... Medicine 99 (34), e21646, 2020 | 19 | 2020 |
| Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro N Aslam, E Abusharieh, D Abuarqoub, D Ali, D Al-Hattab, S Wehaibi, ... Molecular Therapy-Oncolytics 20, 147-165, 2021 | 11 | 2021 |
| A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells NA Ababneh, B Al-Kurdi, F Jamali, A Awidi PeerJ 10, e13003, 2022 | 7 | 2022 |
| Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale H Khalil, ZF Aldaajani, M Aldughmi, A Al‐Sharman, T Mohammad, ... Movement Disorders 37 (4), 826-841, 2022 | 5 | 2022 |
| Safe reversal of motor and sensory deficits by repeated high doses of mesenchymal stem cells in a patient with chronic complete spinal cord injury F Jamali, M Alqudah, R Rahmeh, H Bawaneh, A Al-Shudifat, O Samara, ... The American Journal of Case Reports 24, e938576-1, 2023 | 3 | 2023 |
| A new tool for safety evaluation and a combination of measures for efficacy assessment of cotransplanting human allogenic neuronal stem cells and mesenchymal stem cells for the … F Jamali, M Aldughmi, MW Khasawneh, S Dahbour, AA Salameh, A Awidi JMIR Research Protocols 10 (10), e29695, 2021 | 2 | 2021 |
| Adipose tissue derived mesenchymal stem cells exhibit a superior immune-modulatoery effect on mature dendritic cells compared to bone marrow derived mesenchymal stem cells R Zaza, F Jamali, M Hassouneh, D Alhattab, S AlAlawi, A Awidi Cytotherapy 21 (5), e11, 2019 | 2 | 2019 |
| Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study A Awidi, A Al Shudifat, N El Adwan, M Alqudah, F Jamali, F Nazer, H Sroji, ... Cytotherapy, 2024 | 1 | 2024 |
| Stem Cell Therapies in Neurological Disorders FA Jamali, SS Dahbour Advances in Stem Cell Therapy: Bench to Bedside, 31-59, 2017 | 1 | 2017 |
| Safety and Efficacy of Bone Marrow and Adipose Tissue Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury: A Preliminary Study: BM-MSCs vs AT-MSCs in SCI treatment F Jamali, M Alqudah, S Dahbour, D Alhattab, H Bawa'neh, R Rahmeh, ... Jordan Medical Journal 58 (2), 2024 | | 2024 |
| Human Umbilical Cord–Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study F Jamali, M Aldughmi, S Atiani, A Al-Radaideh, S Dahbour, D Alhattab, ... Cell Transplantation 33, 09636897241233045, 2024 | | 2024 |
| Clinical Relevance of Mesenchymal Stromal Cells from Various Sources: Insights into Transcriptome Analysis for Identifying Inherent Potential DM Alhattab, S Alshehri, F Jamali IntechOpen, 2023 | | 2023 |
| Cross-Cultural Adaptation and Psychometric Evaluation of the Multiple Sclerosis Walking Scale-12 Arabic Version M Aldughmi, F Jamali, A Al-Sharman Multiple Sclerosis and Related Disorders 80, 105277, 2023 | | 2023 |
| Tobacco Smoke and Sleep Quality Among People with Multiple Sclerosis: A Comparison Study M Aldughmi, F Jamali, A Al-Sharman, W Al-Delaimy Multiple Sclerosis and Related Disorders 71, 104275, 2023 | | 2023 |
| Anti-Oncogenic Activities Exhibited By Secretomes Of Mesenchymal Stem Cells Are Mediated By Modulation Of KITLG and DKK1 Genes In Glioma Stem Cells. N Aslam, E Abusharieh, D Abuarqoub, D Ali, D Al-Hattab, S Wehaibi, ... | | 2020 |
| Natural conditioning of mesenchymal stem cells from multiple sclerosis patients enhances their immune-modulating potential F Jamali, M Hassouneh, D Alhattab, H Khwaireh, A Awidi Cytotherapy 21 (5), e12, 2019 | | 2019 |
